Endo, Inc. has announced its financial results for the successor three and six months ended June 30, 2024, and the predecessor periods ending on April 23, 2024, and June 30, 2023. They have attached their earnings release as Exhibit 99.1. The company uses non-GAAP as well as GAAP financial measures to assess performance, excluding certain items to provide consistent cross-period comparisons. Their non-GAAP policy is annually reviewed by their Audit & Finance Committee.
Adjusted financial measurements include adjusted net income, gross profit, operating expenses, diluted net income per share, gross margin, operating expenses, income taxes, effective tax rate, EBITDA, and Adjusted EBITDA. Endo, Inc. emphasizes that adjusted financial measures should be seen as supplemental, and not a substitute for GAAP measures. They also note difficulties in providing reconciliations of projected non-GAAP financial measures due to uncertainties regarding future adjustments. This report is signed by Matthew J. Maletta, Executive Vice President, Chief Legal Officer, and Company Secretary.
Names Mentioned: - Endo, Inc. - Matthew J. Maletta